PROTEOMIC MAPPING OF MYELIN AND ITS MEMBRANE SUBDOMAINS

髓磷脂及其膜亚域的蛋白质组图谱

基本信息

项目摘要

DESCRIPTION (provided by applicant): Myelin is a dynamic, functionally active membrane in bi-directional communication with the axon and receiving and processing signals from the environment. We propose that a key to understanding the active biological functions of myelin is to identify and characterize functionally the complete repertoire of myelin proteins, i.e., the Myelin Proteome. We have undertaken an extensive proteomic analysis of myelin, developed a 2D-PAGE map of myelin proteins, identified to date 125 of these proteins, and illustrated the power and utility of this approach through specific applications of comparative proteomics. This proteomic map and related conceptual approaches offers a major advance for investigations into the diverse biological roles of the myelin membrane and suggest a paradigm for similar studies in other neural systems. The long range goals of this project are to identify and characterize the molecular components of the myelin membrane; develop a model for the arrangement of these molecules in the myelin membrane, with a particular focus on the role of glycosphingolipid-cholesterol microdomains; assign functional correlates to proteins central to myelin biogenesis, maintenance and activity; and relate these concepts to a better understanding of de/remyelination in multiple sclerosis and other demyelinating diseases. Myelin Protein Identity: In Aim I we further develop the Myelin Proteome, applying new approaches for identification of unresolved proteins. This study is providing an invaluable myelin protein database for the myelin biology community at large, forming the basis for numerous projects. Myelin Protein Function: In Aim II we investigate OL differentiation- and physiology-mediated changes in protein expression using Direct In-Gel Electrophoresis (DIGE) and Isotope-Coded Affinity Tag (ICAT) mass spectrometric methodologies, and manipulation of protein expression and function using antibody blocking, RNAi technology and genetically modified mouse mutants. Myelin Protein Disease: In Aim III, we study mechanisms by which cell signaling pathways become activated by environmental factors in normal OL physiology and in myelin biology disease. This focuses on proteomic analyses of antibody perturbations that mimic natural ligands and neuroimmunological disease conditions, including the roles of Myelin Oligodendrocyte Glycoprotein (MOG), galactosphingolipids, and glycosphingolipid-cholesterol microdomains in the initiation of signal transaction.
描述(由申请人提供):髓磷脂是一种动态的功能活性膜,与轴突双向通信,并接收和处理来自环境的信号。我们提出,理解髓鞘活性生物学功能的关键是识别和功能表征髓鞘蛋白的完整库,即,髓鞘蛋白质组我们已经进行了广泛的髓鞘蛋白质组学分析,开发了髓鞘蛋白质的2D-PAGE图谱,确定到目前为止,这些蛋白质中的125个,并通过比较蛋白质组学的具体应用说明了这种方法的力量和实用性。这种蛋白质组学图谱和相关的概念方法为研究髓鞘膜的不同生物学作用提供了重大进展,并为其他神经系统的类似研究提供了范例。该项目的长期目标是确定和表征髓鞘膜的分子成分;开发这些分子在髓鞘膜中排列的模型,特别关注鞘糖脂-胆固醇微结构域的作用;分配与髓鞘生物发生、维持和活性相关的蛋白质的功能;并将这些概念与更好地理解多发性硬化症和其他脱髓鞘疾病中的脱髓鞘/髓鞘再生联系起来。髓磷脂蛋白质的身份:在目的一,我们进一步发展的髓磷脂蛋白质组,应用新的方法来识别未解决的蛋白质。这项研究为髓鞘生物学社区提供了一个非常宝贵的髓鞘蛋白数据库,为许多项目奠定了基础。髓鞘蛋白功能:在目的II中,我们研究OL分化和生理介导的蛋白质表达的变化,使用直接凝胶电泳(DIGE)和同位素编码的亲和标签(ICAT)质谱方法,并操纵蛋白质表达和功能,使用抗体阻断,RNAi技术和转基因小鼠突变体。髓鞘蛋白疾病:在目的III中,我们研究了细胞信号通路在正常OL生理学和髓鞘生物学疾病中被环境因素激活的机制。这侧重于蛋白质组学分析的抗体扰动,模拟天然配体和神经免疫疾病的条件下,包括髓鞘少突胶质细胞糖蛋白(MOG),半乳糖鞘脂,和鞘糖脂胆固醇微结构域的信号处理的启动中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN E PFEIFFER其他文献

STEVEN E PFEIFFER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN E PFEIFFER', 18)}}的其他基金

PROTEOMIC MAPPING OF MYELIN AND ITS MEMBRANE SUBDOMAINS
髓磷脂及其膜亚域的蛋白质组图谱
  • 批准号:
    6394410
  • 财政年份:
    2000
  • 资助金额:
    $ 41.78万
  • 项目类别:
PROTEOMIC MAPPING OF MYELIN AND ITS MEMBRANE SUBDOMAINS
髓磷脂及其膜亚域的蛋白质组图谱
  • 批准号:
    6651025
  • 财政年份:
    2000
  • 资助金额:
    $ 41.78万
  • 项目类别:
PROTEOMIC MAPPING OF MYELIN AND ITS MEMBRANE SUBDOMAINS
髓磷脂及其膜亚域的蛋白质组图谱
  • 批准号:
    6529674
  • 财政年份:
    2000
  • 资助金额:
    $ 41.78万
  • 项目类别:
PROTEOMIC MAPPING OF MYELIN AND ITS MEMBRANE SUBDOMAINS
髓磷脂及其膜亚域的蛋白质组图谱
  • 批准号:
    6794613
  • 财政年份:
    2000
  • 资助金额:
    $ 41.78万
  • 项目类别:
PROTEOMIC MAPPING OF MYELIN AND ITS MEMBRANE SUBDOMAINS
髓磷脂及其膜亚域的蛋白质组图谱
  • 批准号:
    6286773
  • 财政年份:
    2000
  • 资助金额:
    $ 41.78万
  • 项目类别:
CLONAL LINES OF THE NERVOUS SYSTEM
神经系统的克隆系
  • 批准号:
    2262265
  • 财政年份:
    1977
  • 资助金额:
    $ 41.78万
  • 项目类别:
CLONAL LINES OF THE NERVOUS SYSTEM
神经系统的克隆系
  • 批准号:
    6343803
  • 财政年份:
    1977
  • 资助金额:
    $ 41.78万
  • 项目类别:
CLONAL LINES OF THE NERVOUS SYSTEM
神经系统的克隆系
  • 批准号:
    3394338
  • 财政年份:
    1977
  • 资助金额:
    $ 41.78万
  • 项目类别:
CLONAL LINES OF THE NERVOUS SYSTEM
神经系统的克隆系
  • 批准号:
    2036982
  • 财政年份:
    1977
  • 资助金额:
    $ 41.78万
  • 项目类别:
CLONAL LINES OF THE NERVOUS SYSTEM
神经系统的克隆系
  • 批准号:
    6139458
  • 财政年份:
    1977
  • 资助金额:
    $ 41.78万
  • 项目类别:

相似海外基金

Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 41.78万
  • 项目类别:
Orbitrap Eclipse Tribrid Mass Spectrometer as a Regional Resource
Orbitrap Eclipse Tribrid 质谱仪作为区域资源
  • 批准号:
    10629013
  • 财政年份:
    2023
  • 资助金额:
    $ 41.78万
  • 项目类别:
Tissue systems biology of immune dysregulation in aging by single cell spatial metabolomics
通过单细胞空间代谢组学研究衰老过程中免疫失调的组织系统生物学
  • 批准号:
    10647249
  • 财政年份:
    2023
  • 资助金额:
    $ 41.78万
  • 项目类别:
Resistance mechanisms to autophagy-modulating therapies
自噬调节疗法的耐药机制
  • 批准号:
    10345115
  • 财政年份:
    2022
  • 资助金额:
    $ 41.78万
  • 项目类别:
Targeting Castration Resistant Prostate Cancer via Potent Inhibition of Signaling Lipids
通过有效抑制信号脂质来治疗去势抵抗性前列腺癌
  • 批准号:
    10522038
  • 财政年份:
    2022
  • 资助金额:
    $ 41.78万
  • 项目类别:
Pharmacokinetic and pharmacodynamic assessment of peptide-based therapy DA1 for the treatment of Alzheimer's disease
用于治疗阿尔茨海默病的肽疗法 DA1 的药代动力学和药效学评估
  • 批准号:
    10546403
  • 财政年份:
    2022
  • 资助金额:
    $ 41.78万
  • 项目类别:
Functionalized lipid inactosomes to bind and clear SARS-CoV-2
功能化脂质内切体结合并清除 SARS-CoV-2
  • 批准号:
    10370745
  • 财政年份:
    2022
  • 资助金额:
    $ 41.78万
  • 项目类别:
Resistance mechanisms to autophagy-modulating therapies
自噬调节疗法的耐药机制
  • 批准号:
    10565868
  • 财政年份:
    2022
  • 资助金额:
    $ 41.78万
  • 项目类别:
Photocleavable Mass-Tags for Spatial Multiomics of Alzheimer’s Brain Tissue
用于阿尔茨海默病脑组织空间多组学的光裂解质量标签
  • 批准号:
    10684250
  • 财政年份:
    2022
  • 资助金额:
    $ 41.78万
  • 项目类别:
Photocleavable Mass-Tags for Spatial Multiomics of Alzheimer’s Brain Tissue
用于阿尔茨海默病脑组织空间多组学的光裂解质量标签
  • 批准号:
    10483988
  • 财政年份:
    2022
  • 资助金额:
    $ 41.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了